Difference between revisions of "Template:Androgens and antiandrogens"
Jump to navigation
Jump to search
blackwiki>Boghog (added Galeterone) |
blackwiki>Boghog (designated development phases) |
||
| Line 8: | Line 8: | ||
| group2 = [[Selective androgen receptor modulator|SARM]] | | group2 = [[Selective androgen receptor modulator|SARM]] | ||
| − | | list2 = [[AC-262,356]] • [[Andarine]]('''S-4''') • [[BMS-564,929]] • [[LGD-2226]] • [[LGD-3303]] • [[Ostarine]]('''MK-2866''') • [[S-23 (drug)|S-23]] • [[S-40503]] | + | | list2 = [[AC-262,356]]<sup>§</sup> • [[Andarine]] ('''S-4''')<sup>§</sup> • [[BMS-564,929]]<sup>§</sup> • [[LGD-2226]]<sup>§</sup> • [[LGD-3303]]<sup>§</sup> • [[Ostarine]] ('''MK-2866''')<sup>§</sup> • [[S-23 (drug)|S-23]]<sup>§</sup> • [[S-40503]]<sup>§</sup> |
| group3 = [[Antiandrogen]] | | group3 = [[Antiandrogen]] | ||
| − | | list3 = [[Bicalutamide]] • [[Cyproterone]] • [[Dienogest]] • [[Flutamide]] • [[Galeterone]] • [[MDV3100]] • [[Nilutamide]] • [[Spironolactone]] | + | | list3 = [[Bicalutamide]] • [[Cyproterone]] • [[Dienogest]] • [[Flutamide]] • [[Galeterone]]<sup>§</sup> • [[MDV3100]]<sup>†</sup> • [[Nilutamide]] • [[Spironolactone]] |
| group4 = [[Enzyme inhibitor]]s | | group4 = [[Enzyme inhibitor]]s | ||
| Line 21: | Line 21: | ||
| group4 = [[CYP17A1]] inhibitors | | group4 = [[CYP17A1]] inhibitors | ||
| − | | list4 = [[Abiraterone]] • [[Galeterone]] | + | | list4 = [[Abiraterone]] • [[Galeterone]]<sup>§</sup> |
}} | }} | ||
